Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026
COVID-19 ¹é½ÅÀÇ ÇâÈÄ »ç¿ë¿¡ ´ëÇØ ¼¼°¡ÁöÀÇ ´Ù¸¥ ÀáÀçÀû ½Ã³ª¸®¿À°¡ ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
ù¹øÂ° ½Ã³ª¸®¿À¿¡¼´Â COVID-19 ¹é½Å ¿¬Â÷ Á¢Á¾ÀÌ ÇÊ¿äÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. µÎ¹øÂ° ½Ã³ª¸®¿À¿¡¼´Â 65¼¼ ÀÌ»ó °íÀ§Ç豺¿¡°Ô´Â ¸Å³â ¹é½Å Á¢Á¾À» »óÁ¤Çϰí, 65¼¼ ÀÌÇÏ¿¡°Ô´Â 2³â¿¡ Çѹø¾¿ ¹é½Å Á¢Á¾ÀÌ ÇÊ¿äÆÈ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ¼¼¹øÂ° ½Ã³ª¸®¿À¿¡¼´Â 65¼¼ ÀÌ»ó °íÀ§Ç豺Àº 2³â¸¶´Ù COVID-19 ¹é½ÅÀ» Á¢Á¾Çϰí, 65¼¼ ÀÌÇÏ´Â 5³â¸¶´Ù ¹é½ÅÀ» Á¢Á¾Çصµ ±¦Âú´Ù°í ÇÏ´Â °ÍÀÔ´Ï´Ù.
Äڷγª19(COVID-19) ¹é½Å ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, Áúȯ °³¿ä, ÃæÁ·µÇÁö ¾ÊÀº ¿å±¸¿Í ±âȸ, ¿¬±¸°³¹ß µ¿Çâ, ÆÄÀÌÇÁ¶óÀÎ °³¿ä¿Í Á¦Ç° °³¿ä µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå Áúº´ °³¿ä
Á¦3Àå ¿ªÇÐ
Á¦4Àå ÇöÀçÀÇ ¹é½Å Á¢Á¾ ¿É¼Ç
Á¦5Àå ÃæÁ·µÇÁö ¾ÊÀº ¿å±¸¿Í ±âȸ
Á¦6Àå ÆÄÀÌÇÁ¶óÀÎ Æò°¡
Á¦7Àå ¿¬±¸°³¹ß Àü·«
Á¦8Àå ½ÃÀå Àü¸Á
Á¦9Àå ºÎ·Ï
Á¦10Àå ¹®ÀÇ
LSH 21.08.19
The Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026 gives a COVID-19 disease overview, epidemiology overview, current marketed vaccines, unmet needs, pipeline assessment, and market outlook.
GlobalData forecast three different potential scenarios for the future use of COVID-19 vaccines -
- The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
- The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
- In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.
Scope
This report includes -
- Executive Summary
- Disease Overview: History of the outbreak, Etiology and Pathophysiology
- Epidemiology
- Current Vaccination Options: Includes detailed product profiles with SWOT analysis
- Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
- Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
- R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
- Market Outlook
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Table of Contents
1 Executive Summary
2 Disease Overview
3 Epidemiology
4 Current Vaccination Options
5 Unmet Needs and Opportunities
6 Pipeline Assessment
7 R&D Strategies
8 Market Outlook
9 Appendix
10 Contact Us